Effect of aerosolized furosemide on the oxygen requirement of preterm neonates

Not Applicable

Recruiting

• Conditions: Chronic lung disease of preterm neonates (CLD).; Acute drug-induced interstitial lung disorders; J70.2

• Registration Number: IRCT20140311016936N2
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Preterm neonates with gestational age < 32 weeks
Preterm neonates with birth weight <1500gr
Preterm neonates with age> 10 days
Preterm neonates who require oxygen

Exclusion Criteria

Neonate with major congenital anomalies
Neonate with cyanotic heart disease
Neonate with renal failure disease
Patient who needs corticosteroids in hospital course

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ca/Cr ratio of urine. Timepoint: Daily. Method of measurement: Laboratory measurement.;BUN ,Na, K serum. Timepoint: Before drug administration, 49 hours and 97 hours after first doses of drug. Method of measurement: Laboratory measurement.;ABG. Timepoint: Before drug administration, one hour after second and third dose. Method of measurement: Laboratory measurement.